Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer

Journal of Clinical Microbiology

Volumn 37, Issue 12, 1999, Pages 3896-3900

  Redding, Spencer W ^a   Zellars, Richard C ^a   Kirkpatrick, William R ^a   McAtee, Robert K ^a   Caceres, Marta A ^a   Fothergill, Annette W ^a   Lopez Ribot, Jose L ^a   Bailey, Cliff W ^a   Rinaldi, Michael G ^a   Patterson, Thomas F ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE;

ARTICLE; CANCER RADIOTHERAPY; CANDIDIASIS; CLINICAL ARTICLE; HEAD AND NECK CARCINOMA; HUMAN; INFECTION PREVENTION; MINIMUM INHIBITORY CONCENTRATION; MORBIDITY; MOUTH INFECTION; NONHUMAN; PHARYNGITIS; PRIORITY JOURNAL;

CANDIDA; CANDIDA ALBICANS;

EID: 0032723144     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.12.3896-3900.1999     Document Type: Article

References (27)

1. Boken, D. J., S. Swindels, and M. G. Rinaldi. 1993. Fluconazole-resistant Candida albicans. Clin. Infect. Dis. 17:1018-1021.
2. Doebbling, B. N., R. F. Lehmenn, R. J. Hollis, L. C. Wu, A. F. Widmer, A. Voss, and M. A. Pfaller. 1993. Comparison of pulsed-field gel electrophoresis with isoenzyme profiles as a typing system for Candida tropicalis. Clin. Infect. Dis. 16:377-383.
3. Fotos, P. G., and J. W. Hellstein. 1992. Candida and candidosis. Dent. Clin. N. Am. 36:857-878.
4. Goodman, J. L., D. J. Winston, R. A. Greenfield, et al. 1992. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N. Engl. J. Med. 362:845-851.
5. Haveman, C. W., and S. W. Redding. 1998. Dental management and treatment of xerostomic patients. Texas Dent. J. 115:43-56.
6. Isenberg, H. D. (ed.). 1992. Clinical microbiology procedures handbook. American Society for Microbiology, Washington, D.C.
7. Just-Nübling, G., G. Gentschew, K. Mebner, et al. 1991. Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients. Eur. J. Clin. Microbiol. Infect. Dis. 10:917-921.
8. Kirkpatrick, W. R., R. K. McAtee, J. L. Lopez-Ribot, A. W. Fothergill, D. I. McCarthy, M. D. Rinaldi, and T. F. Patterson. 1998. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus- infected patients in North America by primary CHROM agar Candida screening and susceptibility testing of isolates. J. Clin. Microbiol. 36:3007-3012.
9. López-Ribot, J. L., R. K. AcAtee, L. N. Lee, W. R. Kirkpatrick, T. C. White, D. Sanglard, and T. F. Patterson. 1998. Distinct patterns of gene expression associated with development of fluconazole resistance in serial Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrob. Agents Chemother. 42:2932-2937.
10. López-Ribot, J. L., R. K. McAtee, L. N. Lee, W. R. Kirkpatrick, M. G. Rinaldi, and T. F. Patterson. Molecular mechanisms of resistance to azoles in Candida albicans: multiple resistant phenotypes coexist during the same episode of oropharyngeal candidiasis in human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother., in press.
11. Magee, P. T., L. Bowdin, and J. Staudinger. 1992. Comparison of molecular typing methods for Candida albicans. J. Clin. Microbiol. 30:2674-2679.
12. Meunier, F., M. Aoun, and M. Gerard. 1990. Therapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs ketoconazole. Rev. Infect. Dis. 12(Suppl. 3):S364-S368.
13. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. NCCLS document M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
14. Patterson, T. F., S. G. Revankar, W. R. Kirkpatrick, O. Dib, A. W. Fothergill, S. W. Redding, D. A. McGough, and M. G. Rinaldi. 1996. A simple method for detecting fluconazole-resistant yeasts with chromogenic agar. J. Clin. Microbiol. 34:1794-1797.
15. Pfaller, M. A., J. Rhine-Chalberg, S. W. Redding, J. Smith, G. Farinacci, A. W. Fothergill, and M. G. Rinaldi. 1994. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J. Clin. Microbiol. 32: 59-64.
16. Pons, V., D. Greenspan, M. Debruin, and the Multicenter Study Group. 1993. Therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized prospective multicenter study of oral fluconazole versus clotrimazole troches. J. Acquir. Immune Defic. Syndr. 6:2322-2326.
17. Ramirez-Amador, V., S. Silverman, P. Mayer, M. Tyler, and J. Quivery. 1997. Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 84:149-153.
18. Redding, S., J. Smith, G. Farinacci, M. Rinaldi, A. Fothergill, J. Rhine-Chalberg, and M. Pfaller. 1994. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS. Clin. Infect. Dis. 18:240-242.
19. Redding, S. W., M. A. Pfaller, S. A. Messer, J. A. Smith, J. Prows, L. L. Bradley, A. W. Fothergill, and M. G. Rinaldi. 1997. Variations in fluconazole susceptibility and DNA subtyping of multiple Candida albicans colonies from patients with AIDS and oral candidiasis suffering one or more episodes of infection. J. Clin. Microbiol. 37:1761-1765.
20. Revankar, S. G., W. R. Kirkpatrick, R. McAtee, O. P. Dib, A. W. Fothergill, S. W. Redding, D. A. McGough, M. G. Rinaldi, and T. F. Patterson. 1996. Detection and significance of fluconazole resistance in oropharyngeal candidiasis in HIV-infected patients. J. Infect. Dis. 174:821-827.
21. Revankar, S. G., O. P. Dib, W. R. Kirkpatrick, R. K. McAtee, A. W. Fothergill, M. G. Rinaldi, S. W. Redding, and T. F. Patterson. 1998. Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole resistant Candida in human immunodeficiency virus-infected patients. Clin. Infect. Dis. 26:960-963.
22. Revankar, S. G., W. R. Kirkpatrick, R. F. McAtee, A. W. Fothergill, S. W. Redding, M. G. Rinaldi, and T. F. Patterson. 1998. Interpretation of trailing endpoints in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards method. Anticrob. Agents Chemother. 36: 153-156.
23. Schmid, J., E. Voss, and D. R. Soll. 1990. Computer-assisted methods for assessing strain relatedness in Candida albicans by fingerprinting with the moderately repetitive sequence Ca 3. J. Clin. Microbiol. 28:1236-1243.
24. Silverman, S., L. Luangjarmekorn, and D. Greenspan. 1984. Occurrence of oral Candida in irradiated head and neck cancer patients. J. Oral Med. 39:194-196.
25. Sullivan, D., K. Haynes, J. Billie, P. Boerlin, L. Rodero, S. Lloyd, M. Herman, and D. Coleman. 1997. Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals. J. Clin. Microbiol. 35:960-964.
26. Vasquez, J. A., A. Beckley, J. D. Sobel, and J. J. Zervos. 1991. Comparison of restriction enzyme analysis and pulsed-field gradient gel electrophoresis as typing systems for Candida albicans. J. Clin. Microbiol. 29:962-967.
27. Winston, D. J., P. H. Chandrasekar, H. M. Lazarus, J. L. Goodman, J. L. Silber, H. Horowitz, et al. 1993. Fluconazole prophylaxis of fungal infection in patients with acute leukemia. Results of a placebo-controlled, double-blind, multicenter trail. Ann. Intern. Med. 118:495-503.